Vacunación en masa contra el sarampión en Chile con la vacuna de virus atenuado de enders
Date
s.d.1966
Metadata
Show full item recordAbstract
In view of the promising results of previous studies, a measles vaccination campaign with Enders attenuated virus vaccine (Edmonston B strain) was undertaken in Chile. The program was carried out in Santiago and in the southern provinces. Up to April 1964, 85,000 children under the age of five had been vaccinated. Between 10 and 12 per cent of the children vaccinated had postvaccinal variations, in particular eruptions or high fever. It was noted that there was a difference in the reactions produced by vaccines from different batches. There were 26 cases of postvaccinal complications but all quickly recovered. In addition, there were two cases of encephalitis but they also recovered. The epidemiological evaluation of the program was based on the observation of a group of 2,000 children vaccinated prior to 1 July 1965 who were compared with a control group. In the control group only cases of measles occurring after the above-mentioned date were taken into account. Whereas only seven cases of measles were reported in the vaccinated group, none of which were fatal, there were 464 cases in the control group, 25 of which were fatal. These results are an eloquent testimony of the value of mass measles vaccination with Enders attenuated virus vaccine (Edmonston B strain)
Translated title
Mass measles vaccination in Chile with enders attenuated virus vaccine
Subject
Collections
Related items
Showing items related by title, author, creator and subject.
-
Díaz-Ortega, José Luis; Durón-Andino, Regina; Zuñiga-Ocampo, Cesar Omar; Rios- Castillo, José Gerardo; Román-Castro, Eva; González-Ramírez, Luis Humberto; Aguilar-Villaseñor, José Manasés; Jacobo-Ramírez, María Guadalupe (2024-12-19)[RESUMEN]. Objetivo. Describir la experiencia de México en la campaña de vacunación de seguimiento de alta calidad (CVS) contra sarampión y rubéola en niños de 1 a 4 años, y acciones de recuperación de coberturas con ...
-
Belmar-George, Sharon; Cassius-Frederick, Julietta; Leon, Phil; Alexander, Sonia; Holder, Yvette; Lewis-Bell, Karen Nadine; Danovaro-Holliday, M. Carolina; Bravo-Alcántara, Pamela (2018)[ABSTRACT]. Objectives. To more accurately determine coverage and timeliness of the second dose of measles-mumps-rubella vaccine (MMR2), while identifying factors associated with low MMR2 vaccination uptake among children ...
-
Crowcroft, Natasha S.; Minta, Anna A.; Antoni, Sebastien; Ho, Lee Lee; Perea, William; Mulders, Mick N.; Bose, Anindya Sekhar; Wallace, Aaron; Chang Blanc, Diana; O'Connor, Patrick M. (2024-12-19)[ABSTRACT]. Measles and rubella have long been recognized as priorities for disease prevention because of their devastating consequences for child health; hence, all World Health Organization (WHO) regions currently have ...